These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

491 related items for PubMed ID: 15288343

  • 1. Evaluation of SCF-engineered particle-based lactose blends in passive dry powder inhalers.
    Schiavone H, Palakodaty S, Clark A, York P, Tzannis ST.
    Int J Pharm; 2004 Aug 20; 281(1-2):55-66. PubMed ID: 15288343
    [Abstract] [Full Text] [Related]

  • 2. SCF-engineered powders for delivery of budesonide from passive DPI devices.
    Lobo JM, Schiavone H, Palakodaty S, York P, Clark A, Tzannis ST.
    J Pharm Sci; 2005 Oct 20; 94(10):2276-88. PubMed ID: 16136557
    [Abstract] [Full Text] [Related]

  • 3. Dynamic electrostatic charge of lactose-salbutamol sulphate powder blends dispersed from a Cyclohaler®.
    Hoe S, Young PM, Traini D.
    Drug Dev Ind Pharm; 2011 Nov 20; 37(11):1365-75. PubMed ID: 21554161
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of Granulated Lactose as a Carrier for Dry Powder Inhaler Formulations 2: Effect of Drugs and Drug Loading.
    Du P, Du J, Smyth HDC.
    J Pharm Sci; 2017 Jan 20; 106(1):366-376. PubMed ID: 27939234
    [Abstract] [Full Text] [Related]

  • 5. An investigation into the effect of fine lactose particles on the fluidization behaviour and aerosolization performance of carrier-based dry powder inhaler formulations.
    Kinnunen H, Hebbink G, Peters H, Shur J, Price R.
    AAPS PharmSciTech; 2014 Aug 20; 15(4):898-909. PubMed ID: 24756910
    [Abstract] [Full Text] [Related]

  • 6. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
    Zeng XM, MacRitchie HB, Marriott C, Martin GP.
    Int J Pharm; 2007 Mar 21; 333(1-2):45-55. PubMed ID: 17064863
    [Abstract] [Full Text] [Related]

  • 7. Lactose modifications enhance its drug performance in the novel multiple dose Taifun DPI.
    Harjunen P, Lehto VP, Martimo K, Suihko E, Lankinen T, Paronen P, Järvinen K.
    Eur J Pharm Sci; 2002 Sep 21; 16(4-5):313-21. PubMed ID: 12208462
    [Abstract] [Full Text] [Related]

  • 8. Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.
    de Boer AH, Hagedoorn P, Gjaltema D, Goede J, Frijlink HW.
    Int J Pharm; 2006 Mar 09; 310(1-2):81-9. PubMed ID: 16442246
    [Abstract] [Full Text] [Related]

  • 9. Investigations on the Mechanism of Magnesium Stearate to Modify Aerosol Performance in Dry Powder Inhaled Formulations.
    Jetzer MW, Schneider M, Morrical BD, Imanidis G.
    J Pharm Sci; 2018 Apr 09; 107(4):984-998. PubMed ID: 29247741
    [Abstract] [Full Text] [Related]

  • 10. Lactose as a carrier in dry powder formulations: the influence of surface characteristics on drug delivery.
    Zeng XM, Martin GP, Marriott C, Pritchard J.
    J Pharm Sci; 2001 Sep 09; 90(9):1424-34. PubMed ID: 11745794
    [Abstract] [Full Text] [Related]

  • 11. Dry powder inhalers: mechanistic evaluation of lactose formulations containing salbutamol sulphate.
    Kaialy W, Ticehurst M, Nokhodchi A.
    Int J Pharm; 2012 Feb 28; 423(2):184-94. PubMed ID: 22197772
    [Abstract] [Full Text] [Related]

  • 12. Dry powder aerosols generated by standardized entrainment tubes from drug blends with lactose monohydrate: 1. Albuterol sulfate and disodium cromoglycate.
    Xu Z, Mansour HM, Mulder T, McLean R, Langridge J, Hickey AJ.
    J Pharm Sci; 2010 Aug 28; 99(8):3398-414. PubMed ID: 20198688
    [Abstract] [Full Text] [Related]

  • 13. Influence of size and surface roughness of large lactose carrier particles in dry powder inhaler formulations.
    Donovan MJ, Smyth HD.
    Int J Pharm; 2010 Dec 15; 402(1-2):1-9. PubMed ID: 20816928
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of supercritical fluid engineered budesonide powder for respiratory delivery using nebulisers.
    Amani A, Chrystyn H, Clark BJ, Abdelrahim ME, York P.
    J Pharm Pharmacol; 2009 Dec 15; 61(12):1625-30. PubMed ID: 19958584
    [Abstract] [Full Text] [Related]

  • 15. Inhalation performance of pollen-shape carrier in dry powder formulation with different drug mixing ratios: comparison with lactose carrier.
    Hassan MS, Lau R.
    Int J Pharm; 2010 Feb 15; 386(1-2):6-14. PubMed ID: 19922775
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the cohesion-adhesion balance approach to colloidal probe atomic force microscopy and the measurement of Hansen partial solubility parameters by inverse gas chromatography for the prediction of dry powder inhalation performance.
    Jones MD, Buckton G.
    Int J Pharm; 2016 Jul 25; 509(1-2):419-430. PubMed ID: 27265314
    [Abstract] [Full Text] [Related]

  • 17. Influence of carrier on the performance of dry powder inhalers.
    Saint-Lorant G, Leterme P, Gayot A, Flament MP.
    Int J Pharm; 2007 Apr 04; 334(1-2):85-91. PubMed ID: 17113733
    [Abstract] [Full Text] [Related]

  • 18. Nano-salbutamol dry powder inhalation: a new approach for treating broncho-constrictive conditions.
    Bhavna, Ahmad FJ, Mittal G, Jain GK, Malhotra G, Khar RK, Bhatnagar A.
    Eur J Pharm Biopharm; 2009 Feb 04; 71(2):282-91. PubMed ID: 18984050
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.